Roger Sawhney

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger Sawhney:

Company Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. Chief Financial Officer Common Stock 2,941 $23,528 $8.00 03 Aug 2021 Direct
Arbutus Biopharma Corp Director Stock Option (Right to Buy) 157,600 04 Aug 2025 Direct
Omega Therapeutics, Inc. Chief Financial Officer Option (Right to Buy) 60,000 09 Mar 2022 Direct
ACTUATE THERAPEUTICS, INC. Director Non-Qualified Stock Options 30,000 12 Aug 2024 Direct
ACTUATE THERAPEUTICS, INC. Director Stock Options 15,000 22 May 2025 Direct
ALIMERA SCIENCES INC Director Stock Option (Right to Buy) 2,252 25 Feb 2023 Direct

Insider Reports Filed by Roger Sawhney

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABUS Arbutus Biopharma Corp 04 Aug 2025 1 $0 4 Director 06 Aug 2025, 16:08
ABUS Arbutus Biopharma Corp 04 Aug 2025 0 $0 3 Director 06 Aug 2025, 16:06
ACTU ACTUATE THERAPEUTICS, INC. 22 May 2025 1 $0 4 Director 23 May 2025, 16:05
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 1 $0 4 Director 14 Aug 2024, 19:25
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 0 $0 3 Director 14 Aug 2024, 19:23
/report/000147450623000074-sawhney-roger-2023-02-25 ALIMERA SCIENCES INC 25 Feb 2023 1 $0 4 Director 01 Mar 2023, 10:25
/report/000147450623000073-sawhney-roger-2023-02-25 ALIMERA SCIENCES INC 25 Feb 2023 0 $0 3 Director 01 Mar 2023, 10:11
OMGAQ Omega Therapeutics, Inc. 09 Mar 2022 1 $0 4 Chief Financial Officer 11 Mar 2022, 15:05
OMGAQ Omega Therapeutics, Inc. 03 Aug 2021 1 +$49,997 4 Chief Financial Officer 03 Aug 2021, 17:16
OMGAQ Omega Therapeutics, Inc. 29 Jul 2021 0 $0 3 Chief Financial Officer 29 Jul 2021, 21:03